FDA Approves New Oral Antibiotic for Complicated UTIs

The U.S. Food and Drug Administration has granted approval for tebipenem pivoxil, marking the first oral carbapenem antibiotic available for treating complicated urinary tract infections, including pyelonephritis. This decision is based on trial data showing its effectiveness comparable to an intravenous alternative. This new option could offer a more convenient treatment for patients.